NASDAQ : HYFT
MindWalk Holdings Corp. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 56.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 52.77M |
| Enterprise Value | 49.81M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 14, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 47.11M |
| Shares Outstanding | 47.11M |
| Shares Change (YoY) | +22.03% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 9.20% |
| Owned by Institutions (%) | 9.34% |
| Float | 42.74M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.60 |
| Forward PS | 4.02 |
| PB Ratio | 10.78 |
| P/TBV Ratio | 10.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.84 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -123.66% |
| Return on Assets (ROA) | -36.39% |
| Return on Invested Capital (ROIC) | -504.76% |
| Return on Capital Employed (ROCE) | -158.29% |
| Weighted Average Cost of Capital (WACC) | 8.14% |
| Revenue Per Employee | $150,258 |
| Profits Per Employee | -$158,071 |
| Employee Count | 77 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 11.21 |
Taxes
| Measure | Value |
|---|
| Income Tax | -143,278 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -40.11% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 36.17 |
| Average Volume (20 Days) | 298,450 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.01M |
| Short Previous Month | 707,273 |
| Short % of Shares Out | 2.15% |
| Short % of Float | 2.37% |
| Short Ratio (days to cover) | 2.88 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 11.57M |
| Gross Profit | 7.03M |
| Operating Income | -12.05M |
| Pretax Income | -12.33M |
| Net Income | -12.17M |
| EBITDA | -11.47M |
| EBIT | -12.05M |
| Loss Per Share | -$0.26 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 5.43M |
| Total Debt | 2.48M |
| Net Cash | 2.95M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 4.93M |
| Book Value Per Share | 0.10 |
| Working Capital | 3.97M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -8.80M |
| Capital Expenditures | -138,897 |
| Depreciation & Amortization | 579,929 |
| Net Borrowing | -456,783 |
| Free Cash Flow | -8.94M |
| FCF Per Share | -$0.19 |
Margins
| Measure | Value |
|---|
| Gross Margin | 60.79% |
| Operating Margin | -104.16% |
| Pretax Margin | -106.59% |
| Profit Margin | -105.20% |
| EBITDA Margin | -99.17% |
| EBIT Margin | -104.16% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -22.03% |
| Shareholder Yield | -22.03% |
| Earnings Yield | -23.35% |
| FCF Yield | -16.79% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.33 |
| Price Target Difference | 286.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 20.65% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 23, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.78 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |